MIRA Pharmaceuticals, Inc. - Common Stock (NQ:MIRA)

0.7355 +0.0054 (+0.74%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MIRA Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

November 20, 2024

Via ACCESSWIRE

MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain ↗

October 28, 2024

MIRA Pharmaceuticals stock rises as new preclinical data reveal its oral ketamine analog Ketamir-2 is 60% more effective than gabapentin in pain relief.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 28, 2024

Via Benzinga

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain

October 28, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 25, 2024

Via Benzinga

Peering Into Mira Pharmaceuticals's Recent Short Interest ↗

September 11, 2024

Via Benzinga

MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study

August 26, 2024

Via ACCESSWIRE

(MIRA) - Analyzing Mira Pharmaceuticals's Short Interest ↗

July 26, 2024

Via Benzinga

MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action

July 25, 2024

Via ACCESSWIRE

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

October 21, 2024

Via ACCESSWIRE

Breakthrough Therapies And Novel Treatments - This Biopharma Is Out To Change The Game

October 03, 2024

Breakthrough Therapies And Novel Treatments - This Biopharma Is Out To Change The Game

Via News Direct

Topics Cannabis

Why Mira Shares Are Trading Higher Today ↗

September 27, 2024

MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) shares are trading higher Friday following the announcement of promising new preclinical data for its lead development product, Ketamir-2. Here's what you need...

Via Benzinga

MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024

September 27, 2024

Via ACCESSWIRE

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025

September 19, 2024

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025

Via News Direct

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025

September 18, 2024

Via ACCESSWIRE

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA

September 11, 2024

Via ACCESSWIRE

The Potential Of Ketamir-2: A Safer Treatment For Mental Health Disorders And Neuropathic Pain, IND Filing Expected By Year-End

August 27, 2024

The Potential Of Ketamir-2: A Safer Treatment For Mental Health Disorders And Neuropathic Pain, IND Filing Expected By Year-End

Via News Direct

MIRA Pharmaceuticals' Oral Ketamine Analog Achieves Complete Normalization Of Neuropathic Pain In Animal Studies ↗

August 26, 2024

MIRA Pharmaceuticals stock surges on promising preclinical results of oral ketamine analog, Ketamir-2, showing 100% pain threshold normalization in rats, positioning it as a potential breakthrough for...

Via Benzinga

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

August 26, 2024

Via Benzinga

Heico, PDD Holdings And 3 Stocks To Watch Heading Into Monday ↗

August 26, 2024

Via Benzinga

MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End

August 19, 2024

Via ACCESSWIRE

MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024 ↗

August 13, 2024

MIRA stock results show that Mira Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor

August 12, 2024

Via ACCESSWIRE

Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2024

Via Benzinga

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank? ↗

August 01, 2024

A look at the most-searched tickers on Benzinga Pro for the month of July shows some familiar names like Tesla, Nvidia and Apple. Here's a look at the others.

Via Benzinga

MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year

July 29, 2024

MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year

Via News Direct

Topics Cannabis

Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data ↗

July 25, 2024

MIRA Pharmaceuticals stock surged on Thursday following new preclinical data on Ketamir-2, MIRA's novel oral ketamine analog, highlighting its unique selectivity and favorable safety profile for...

Via Benzinga

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 23, 2024

Via Benzinga

Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today? ↗

July 23, 2024

Mira Pharmaceuticals stock is falling on Tuesday but that's only after shares of MIRA underwent a massive rally on Monday.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 23, 2024

Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.